From the discovery of an intestinal extract that could produce hypoglycemia in 1930, to the flourishing development of different kinds of Glucagon‐like pepetide‐1 receptor agonist (GLP‐1RA) advocated in diabetes in recent years, GLP‐1RA has undergone a long way in the application of diabetes. The gene discussed is GCG; the disease is diabetes mellitus.